Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function.

Jain, Sunil M; Balamurugan, Ramanathan; Tandon, Monika; Mozaffarian, Neelufar; Gudi, Girish; Salhi, Yacine; Holland, Robert; Freeman, Roy; Baron, Ralf

Jain, Sunil M; Balamurugan, Ramanathan; Tandon, Monika; Mozaffarian, Neelufar; Gudi, Girish; Salhi, Yacine; Holland, Robert; Freeman, Roy; Baron, Ralf.

Affiliation

Jain SM; TOTALL Diabetes Hormone Institute, Indore, India.
Balamurugan R; Kovai Diabetes Speciality Centre and Hospital, Coimbatore, India.
Tandon M; Clinical Sciences, Glenmark Pharmaceuticals Limited, Mumbai, India.
Mozaffarian N; Janssen Pharmaceuticals, Inc, Cambridge, MA, United States.
Gudi G; Ichnos Sciences, Inc, New York, NY, United States.
Salhi Y; Ichnos Sciences, Inc, New York, NY, United States.
Holland R; Early Clinical Development Consulting Ltd, Macclesfield, United Kingdom.
Freeman R; Department of Neurology, Harvard Medical School, Boston, MA, United States.
Baron R; Division of Neurological Pain Research and Therapy, Universitätsklinikum Schleswig-Holstein, Campus-Kiel, Germany.

Pain ; 163(6): e738-e747, 2022 06 01.

Article in En | MEDLINE | ID: mdl-34490850

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Neuropathies / Chronic Pain / Neuralgia Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Pain Year: 2022 Document type: Article Affiliation country: India Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google